Mico BioMed Co. Ltd. (214610) - Total Liabilities

Latest as of September 2025: ₩7.88 Billion KRW ≈ $5.34 Million USD

Based on the latest financial reports, Mico BioMed Co. Ltd. (214610) has total liabilities worth ₩7.88 Billion KRW (≈ $5.34 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Mico BioMed Co. Ltd. growing its equity to track the company's year-over-year net asset growth rate.

Mico BioMed Co. Ltd. - Total Liabilities Trend (2015–2024)

This chart illustrates how Mico BioMed Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See Mico BioMed Co. Ltd. (214610) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Mico BioMed Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Mico BioMed Co. Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Playtech Plc LSE:PTEC	UK	GBX765.50 Million
Xelpmoc Design And Tech Limited NSE:XELPMOC	India	Rs107.98 Million
Big Pharma Split Corp Class A TO:PRM	Canada	CA$12.62 Million
Immunovia publ AB ST:IMMNOV	Sweden	Skr19.20 Million
S. Pack & Print Public Company Limited BK:SPACK	Thailand	฿559.96 Million
Volcano Bhd KLSE:0232	Malaysia	RM52.09 Million
Pivotal Metals Ltd AU:PVT	Australia	AU$279.63K
Weizmann Limited NSE:WEIZMANIND	India	Rs286.18 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Mico BioMed Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Mico BioMed Co. Ltd. market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mico BioMed Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mico BioMed Co. Ltd. (2015–2024)

The table below shows the annual total liabilities of Mico BioMed Co. Ltd. from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩28.58 Billion ≈ $19.37 Million	+14.38%
2023-12-31	₩24.99 Billion ≈ $16.93 Million	-37.24%
2022-12-31	₩39.82 Billion ≈ $26.98 Million	+9.34%
2021-12-31	₩36.42 Billion ≈ $24.68 Million	+142.82%
2020-12-31	₩15.00 Billion ≈ $10.16 Million	-37.53%
2019-12-31	₩24.01 Billion ≈ $16.27 Million	+30.16%
2018-12-31	₩18.45 Billion ≈ $12.50 Million	+41.64%
2017-12-31	₩13.02 Billion ≈ $8.83 Million	+130.32%
2016-12-31	₩5.65 Billion ≈ $3.83 Million	+0.74%
2015-12-31	₩5.61 Billion ≈ $3.80 Million	--

About Mico BioMed Co. Ltd.

KQ:214610 Korea Publishing

Market Cap

$13.00 Million

₩19.18 Billion KRW

Market Cap Rank

#26343 Global

#1976 in Korea

Share Price

₩2290.00

Change (1 day)

-2.35%

52-Week Range

₩2255.00 - ₩6150.00

All Time High

₩12100.26